Abstract: As seen with some of the natural VOC, the neutralization potencies of
COVID-19 convalescent-phase sera were reduced by 4- to 16-fold against rVSV-SARS2 bearing
Y145D,
K150E, or
W152R spike mutations.
Result: For the NTD MAb (ADI-56479), rVSV-SARS2 neutralization-escape mutations mapped to residues 145 (
Y145D), 150 (
K150E), and 152 (
W152R) in the NTD, and each one of these mutations individually afforded an ~1,000-fold increase in the neutralization IC50 values.
Result: Specifically, the sera showed a drop of 3.5-fold (
Y145D) to 16-fold (
K150E and
W152R) in their neutralization I